Status of Gene-based Hemophilia A and B Therapy - The Fritsma Factor

Jul 26 2025

George Fritsma

Click here for an open-access, in-depth, illustrated review of the worldwide status of gene-based HA and HB therapy: Glasner MF, Pipe S, Miesbach W. Gene-based therapies for hemophilia. Res Pract Thromb Haemost. 2025;9:102870. doi: 10.1016/j.rpth.2025.102870. PMID: 40488175; PMCID: PMC12143782.

Comments (0)

Bleeding Disorders

No comments here.

Leave a Reply Cancel reply

You must be logged in to post a comment.

George Fritsma is a medical laboratory scientist, educator, and author. George is a member of the International Society on Thrombosis and Hemostasis, the International Society for Laboratory Hematology, and the American Society for Clinical Laboratory Science.

Cheat Sheets from George

Quick Question